Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
8.30
0.00 (0.00%)
Apr 30, 2026, 3:04 PM CST
SHE:002898 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 29.21 | 61.02 | 48.84 | 87.12 | 72.27 | 113.31 |
Trading Asset Securities | - | - | - | 2.14 | - | - |
Cash & Short-Term Investments | 29.21 | 61.02 | 48.84 | 89.26 | 72.27 | 113.31 |
Cash Growth | -11.43% | 24.92% | -45.28% | 23.51% | -36.22% | 95.10% |
Accounts Receivable | 147.69 | 159.85 | 99.68 | 55.27 | 88.85 | 84.98 |
Other Receivables | 10.17 | 19.91 | 4.03 | 14.71 | 19.68 | 33.83 |
Receivables | 157.86 | 179.76 | 103.7 | 69.98 | 108.53 | 118.81 |
Inventory | 111.23 | 80.38 | 94.08 | 88.87 | 63.97 | 52.98 |
Other Current Assets | 75.97 | 23.55 | 3.21 | 8.19 | 9.59 | 4.05 |
Total Current Assets | 374.27 | 344.7 | 249.83 | 256.3 | 254.36 | 289.14 |
Property, Plant & Equipment | 342.21 | 347.37 | 402.23 | 352.11 | 394.25 | 405.59 |
Long-Term Investments | - | 4.9 | 4.9 | 69.86 | 62.28 | 45.19 |
Other Intangible Assets | 70.43 | 71.65 | 67.71 | 67 | 67.77 | 70.46 |
Long-Term Deferred Tax Assets | 5.08 | 5.51 | 3.71 | 1.96 | 13.58 | 18.57 |
Long-Term Deferred Charges | 39.29 | 38.86 | 59.16 | 45.74 | 36.7 | 33.23 |
Other Long-Term Assets | 24 | 19.11 | 20.68 | 20.88 | 19.08 | 20.61 |
Total Assets | 855.28 | 832.1 | 808.22 | 813.84 | 848.01 | 882.78 |
Accounts Payable | 142.65 | 99.3 | 62.31 | 63.53 | 94.47 | 94.15 |
Accrued Expenses | 5.63 | 43.31 | 21.03 | 17.55 | 22.39 | 14.55 |
Short-Term Debt | 73.21 | 84.93 | 128.13 | 90.05 | 100.06 | 100.12 |
Current Portion of Long-Term Debt | - | 21.64 | 6.27 | 11.9 | 29.63 | 28.86 |
Current Portion of Leases | - | 3.72 | 0.5 | 0.36 | 0.24 | 0.89 |
Current Income Taxes Payable | 17.71 | 7.07 | - | 0.02 | 0.75 | 0.74 |
Current Unearned Revenue | 15.65 | 3.39 | 11.51 | 11.53 | 23.53 | 8.24 |
Other Current Liabilities | 185.68 | 147 | 25.27 | 32.08 | 25.38 | 19.03 |
Total Current Liabilities | 440.53 | 410.37 | 255.02 | 227.01 | 296.45 | 266.58 |
Long-Term Debt | 7.5 | 8 | 29.86 | 25.08 | 13.32 | 42.91 |
Long-Term Leases | 4.95 | 5.97 | 0.33 | 0.04 | 0.18 | 0.27 |
Long-Term Unearned Revenue | 2.69 | 2.65 | 2.6 | 2.84 | 3.08 | 3.33 |
Long-Term Deferred Tax Liabilities | 11.03 | 11.16 | 9.62 | 9.76 | 8.63 | 6.04 |
Other Long-Term Liabilities | 10.62 | 9.81 | 11.51 | 13.23 | - | - |
Total Liabilities | 477.34 | 447.95 | 308.95 | 277.96 | 321.67 | 319.12 |
Common Stock | 176 | 176 | 176 | 176 | 176 | 176 |
Additional Paid-In Capital | 288.58 | 288.58 | 288.47 | 288.47 | 288.47 | 288.47 |
Retained Earnings | -95.42 | -86.42 | 34.75 | 71.41 | 61.88 | 99.19 |
Comprehensive Income & Other | 2.33 | 2 | 0.06 | - | - | - |
Total Common Equity | 371.49 | 380.15 | 499.28 | 535.88 | 526.35 | 563.66 |
Minority Interest | 6.45 | 4.01 | - | - | - | - |
Shareholders' Equity | 377.94 | 384.15 | 499.28 | 535.88 | 526.35 | 563.66 |
Total Liabilities & Equity | 855.28 | 832.1 | 808.22 | 813.84 | 848.01 | 882.78 |
Total Debt | 85.66 | 124.26 | 165.09 | 127.42 | 143.43 | 173.05 |
Net Cash (Debt) | -56.46 | -63.24 | -116.25 | -38.16 | -71.16 | -59.74 |
Net Cash Per Share | -0.32 | -0.36 | -0.66 | -0.22 | -0.40 | -0.34 |
Filing Date Shares Outstanding | 176 | 176 | 176 | 176 | 176 | 176 |
Total Common Shares Outstanding | 176 | 176 | 176 | 176 | 176 | 176 |
Working Capital | -66.27 | -65.66 | -5.19 | 29.29 | -42.09 | 22.57 |
Book Value Per Share | 2.11 | 2.16 | 2.84 | 3.04 | 2.99 | 3.20 |
Tangible Book Value | 301.06 | 308.5 | 431.56 | 468.89 | 458.58 | 493.21 |
Tangible Book Value Per Share | 1.71 | 1.75 | 2.45 | 2.66 | 2.61 | 2.80 |
Buildings | - | 271.16 | 301.56 | 311.75 | 335.26 | 323.12 |
Machinery | - | 217.25 | 226.12 | 213.31 | 207.43 | 194.92 |
Construction In Progress | - | 5.89 | 5.89 | 1.44 | 1.38 | 9.21 |